contribute to a multidrug-resistant phenotype (1, 19, 24, 27, 38, 42) . However, these systems have been studied mainly in E. coli and S. enterica, and little is known about their roles in K. pneumoniae, and the effects of mutations in the regulator genes on resistance to ␤-lactams are still unclear.
Therefore, the present study had a triple objective: (i) assessing the effect of antibiotic pressure by cefoxitin, on one hand, and by fluoroquinolones, on the other hand, on in vitro selection of resistant mutants overexpressing an efflux system from fully susceptible K. pneumoniae strains; (ii) searching for the presence of mutations in the regulator genes acrR, ramR, ramA, marR, marA, soxR, soxS, and rob in clinical isolates and in in vitro-selected mutants displaying an efflux-related antibiotic cross-resistance pattern; and (iii) determining the impacts of these mutations on the susceptibilities of the different strains to a large panel of antibiotics.
MATERIALS AND METHODS
Bacterial strains. The collection studied comprised (i) 3 previously published K. pneumoniae clinical isolates shown to have cross-resistance to cefoxitin, quinolones, and chloramphenicol (KPBj Eϩ), with increased expression of the acrB gene for 2 of them (KPBj1 Eϩ and KPBj3 Eϩ) (3, 29) ; (ii) their spontaneous revertants (KPBj Rev) susceptible to the three antibiotic families (3); and (iii) mutants selected from these 3 revertant strains with cefoxitin, ciprofloxacin, or levofloxacin. For all experiments, K. pneumoniae strain ATCC 138821 was used as a control.
In vitro selection of mutants. Mutants were selected by using the procedure previously described by Miller et al. (22) . Briefly, 5 l of an overnight culture was transferred into 9 ml of fresh Mueller-Hinton (MH) broth containing ciprofloxacin (Sigma Aldrich, Saint-Quentin-Fallavier, France), levofloxacin (Sigma Aldrich), or cefoxitin (Panpharma, Fougères, France) at 0.25ϫ MIC for the strain tested and incubated for 18 h at 37°C. Such growth conditions were repeated until mutants were obtained from overnight culture aliquots plated after each broth culture cycle on MH agar containing 4ϫ the original MIC.
Antibiotic susceptibility. The susceptibilities of the in vitro-selected mutants to the well-known markers of efflux system overexpression (i.e., cefoxitin, nalidixic acid, and chloramphenicol) were determined by using the agar disk diffusion method. Only the mutants displaying cross-resistance to these 3 antibiotics were further studied. Susceptibility to a large panel of antibiotics, including ␤-lactams (cefoxitin, amoxicillin, and amoxicillin associated with clavulanic acid, ticarcillin, cefazolin, cefuroxime, cefotaxime, ceftazidime, ertapenem, imipenem, meropenem, and doripenem), quinolones (nalidixic acid, ciprofloxacin, and levofloxacin), chloramphenicol, tetracycline, and tigecycline, was determined by the agar dilution method. MIC determination, replicated 3 times, was performed and interpreted following the recommendations of the French Antibiogram Committee [http://www.sfm.asso.fr/nouv/general.php?paϭ2].
Real-time RT-PCR for analysis of gene expression. The transcription (mRNA) levels of the acrB, ramA, and soxS genes were determined according to the method previously described by Doumith et al. (10) . Briefly, total cellular RNA was extracted using the RNeasy Mini kit (Qiagen, Courtaboeuf, France) and treated with RNase-free DNase (Qiagen) for 30 min at 37°C, after which a second step of purification was performed. Reverse transcription (RT)-PCR was carried out in a LightCycler using the one-step LightCycler RNA Master SYBR green I kit (Roche Applied Science, Meylan, France) and the primers listed in Table 1 . The specificity of the generated products was tested by melting-point analysis. Amplifications were performed in duplicate from two different RNA preparations. The cycle threshold (C T ) values of the target genes were compared with the C T values of the housekeeping rpoB gene, chosen as an endogenous reference for normalizing the transcription levels of the target genes. Strain ATCC 138821 was used as a control, and the normalized relative expression of 
Analysis of gene sequences. The presence of mutations in the gyrA and parC genes, which encode targets for quinolones, and in the acrR, ramR, ramA, marR, marA, soxR, soxS, and rob genes was assessed by PCR and sequencing. The sequences of the primers used, as well as the annealing temperature (T m ), for each gene are shown in Table 1 (7) . PCR was performed with a 0.2 M concentration of each primer, a 500 M concentration of the deoxynucleoside triphosphates (dNTPs), 1ϫ PCR buffer with MgCl 2 , and 2.5 U of Taq DNA polymerase per 50-l reaction mixture. After a 5-min denaturation at 95°C, amplification was performed for 35 cycles of 1 min at 95°C, 1 min at T m , and 1 min at 72°C, with a final extension of 10 min at 72°C. After purification of the PCR products on Bio-Gel P-100 polyacrylamide gel (Bio-Rad, Marne-la-Coquette, France) columns, the presequencing amplification reaction was performed with a BigDye Terminator v1.1 Cycle Sequencing Kit (Applied Biosystems, Courtaboeuf, France) according to the manufacturer's protocol. The PCR products obtained were then purified on Sephadex G-50 (Amersham Biosciences, Orsay, France) columns and sequenced on the 3130xl Genetic Analyzer (Applied Biosystems). The presence of mutations in the amplified regions was assessed by multiple-sequence alignments using CLUSTALW (http://www.ebi .ac.uk/Tools/msa/clustalw2/). Nucleic acid sequences were then translated into corresponding protein sequences using the EMBOSS Transeq application (http://www.ebi.ac.uk/Tools/emboss/transeq/), in order to further analyze the consequences of the mutations observed.
Complementation with the wild-type ramR or soxR gene. The 895-bp ramR fragment, generated by PCR using primers RamR F and RamR R (Table 1) from the genomic DNA of strain ATCC 138821, was cloned into the pSC-Aamp/kan plasmid vector using a StrataClone PCR Cloning Kit (Agilent Technologies, Massy, France). The same procedure was carried out for the 617-bp soxR fragment, using primers SoxR F and SoxR R ( Table 1 ). The empty plasmid pSC-A-amp/kan-E1, used as a negative control, was generated from pSC-A-amp/ kan-ramR after digestion with EcoRI enzyme (Ozyme, Saint-Quentin-en-Yvelines, France) and ligation with the LigaFast Rapid DNA Ligation System (Promega, Charbonnières-les-Bains, France). All constructs were verified by sequencing them. The cloned wild-type ramR and soxR genes were transferred into electrocompetent ramR and soxR mutant strains, respectively, by transformation with the recombinant plasmids pSC-A-amp/kan-ramR and pSC-A-amp/ kan-soxR.
Nucleotide sequence accession numbers. The sequences determined in this study have been submitted to GenBank, and their corresponding accession numbers are presented in Table 2 .
RESULTS
Antibiotic resistance pattern of the mutants. Resistant mutants were obtained after one or two passages in low antibiotic concentrations from the susceptible KPBj Rev strains with a frequency of approximately 10 Ϫ6 when ciprofloxacin or levofloxacin was used as a selector and 2 ϫ 10 Ϫ6 when cefoxitin was used. Four of the 9 mutants selected with cefoxitin presented a low level of resistance only to that molecule and remained susceptible to nalidixic acid and chloramphenicol. The remaining 5 mutants, similarly to the mutants selected with ciprofloxacin (n ϭ 6) or levofloxacin (n ϭ 6), displayed cross-resistance to the 3 antibiotics, suggesting the selection of mutants overexpressing an efflux system. These 17 mutants were retained for further analysis, after having been checked for the absence of mutations in both the gyrA and parC genes.
Transcription of the acrB gene. The relative transcription levels of acrB for the 3 KPBj Rev strains and their respective mutants are shown in Table 3 . There was a notable increase in acrB transcription for all the mutants selected by both cefoxitin and fluoroquinolones from strains KPBj1 Rev and KPBj3 Rev compared with the parental strains: 2.9 to 6.1 times and 1.8 to 4.2 times, respectively. This increase (2.8 to 10 times) was observed for all of the mutants originating from strain KPBj5 Rev except one, mutant KPBj5 M1 Cip, for which the level of transcription of acrB was equivalent to that of the parental strain.
Sequences of the regulator genes. We analyzed the sequences of the regulator genes acrR, ramR, ramA, marR, marA, soxR, soxS, and rob of the 3 clinical isolates (KPBj Eϩ), the 3 revertant strains (KPBj Rev), and the 17 mutants. First, we compared the sequences of the genes of each KPBj Rev strain with those of the 3 K. pneumoniae strains available in the GenBank database, i.e., K. pneumoniae subsp. pneumoniae MGH 78578 (accession number NC_009648) (25) , K. pneumoniae 342 (accession number NC_011283) (11), and K. pneumoniae NTUH-K2044 (accession number NC_012731) (44) . Whatever the gene, in strains KPBj1 Rev and KPBj5 Rev, the sequences were either strictly identical to those of strains MGH 78578 and NTUH-K2044 or displayed only one or two silent polymorphisms. For strain KPBj3 Rev, all the genes studied had sequences considerably different from those of strains MGH 78578 and NTUH-K2044 but very similar to those of strain 342, except for the ramR gene. Indeed, in strain 342, this gene showed a 96-bp deletion, resulting in the deletion of 32 amino acids approximately in the middle of the RamR protein. Such a deletion was not observed in the ramR gene of strain KPBj3 Rev, although the other polymorphisms characteristic of strain 342, compared with strain MGH 78578, were present.
Second, we compared the sequences of the regulator genes of the 3 clinical isolates and of the 17 mutants, which all showed cross-resistance to cefoxitin, nalidixic acid, and chloramphenicol, with those of the corresponding revertant strain. No mutation was detected in the 8 regulator genes studied from the 3 clinical isolates and 8 of the 17 mutants. However, point mutations within the ramR gene were detected in 8 of the 9 remaining mutants. In 7 of the ramR mutants, there were single-nucleotide substitutions, occurring at 6 different positions, whereas there was a deletion of 1 nucleotide in the last one. These genetic changes were distributed all along the ramR Rev  GU985172  HM036711  GU985178  HM010916  HM036717  HQ992823  KPBj1 Eϩ  GU985173  HM036712  GU985179  HM010917  HM036718  HQ992824  KPBj3 Rev  GU985174  HM036713  GU985180  HM010918  HM036719  HQ992825  KPBj3 Eϩ  GU985175  HM036714  GU985181  HM010919  HM036720  HQ992826  KPBj5 Rev  GU985176  HM036715  GU985182  HM010920  HM036721  HQ992827  KPBj5 Eϩ  GU985177  HM036716  GU985183  HM010921  HM036722  HQ992828 VOL. 55, 2011 MOLECULAR ANALYSIS OF EFFLUX SYSTEM REGULATOR GENES 2797
on June 23, 2017 by guest http://aac.asm.org/ gene and led either to an amino acid exchange or to occurrence of a premature stop codon (directly or resulting from a frameshift mutation) and synthesis of a truncated RamR protein (Fig. 1) . Finally, in the 9th mutant, KPBj5 M1 Cip, we found a point mutation in the soxR gene (C375G) that resulted in an amino acid substitution (N125K) in the SoxR protein (Fig. 2) . Functional impacts of the mutations observed in the ramR and soxR genes. The expression levels of the genes ramA and soxS, encoding the transcriptional activators RamA and SoxS, were measured for the mutants in which genetic changes were detected in ramR and soxR, respectively. In all the ramR mutants, we observed a dramatic increase in the ramA transcription level, up to 80 times that of the parental strain ( Table 3) . The soxR mutant, KPBj5 M1 Cip, showed an increase in the soxS transcription level compared to the parental strain, KPBj5
Rev, although this increase was lower than for the ramA gene (Table 3) .
In order to demonstrate that the mutations found in the ramR and soxR regulator genes caused the observed efflux system overexpression, phenotypically characterized by antibiotic cross-resistance, we complemented the ramR and soxR mutants with the cloned wild-type ramR and soxR genes, respectively. For all the ramR mutants, introduction of the wildtype ramR gene strikingly lowered the transcription level of ramA and also suppressed the overexpression of the acrB gene (Table 3) . For the soxR mutant, complementation with the wild-type soxR gene normalized the transcription level of soxS. However, it had no effect on acrB expression, consistent with the fact that KPBj5 M1 Cip was the only mutant that did not overexpress the acrB gene (Table 3) . Impact of efflux system overexpression on antibiotic susceptibility. The MICs of members of different antibiotic families, including quinolones, chloramphenicol, cyclines, and ␤-lactams, among which were different penicillins, cephalosporins, and carbapenems, for the 3 clinical isolates, their 3 revertants, and the different types of mutants (with identified and with unknown mutations) that all displayed an overexpressed effluxrelated resistance phenotype were measured (Table 4) . When mutants selected with a given antibiotic from the same parental strain had the same sequence for their regulator genes (KPBj1 M1 Cip and KPBj1 M2 Cip, KPBj3 M1 Cip and KPBj3 M2 Cip, and KPBj3 M1 Lev and KPBj3 M2 Lev), MICs were determined for only one of them. As had previously been shown (3), the spontaneously reverted KPBj Rev strains obtained from the KPBj Eϩ clinical isolates were fully susceptible to all the antibiotics tested except amoxicillin and ticarcillin, consistent with the natural resistance profile of the K. pneumoniae species. For the 14 mutants tested, the MICs of quinolones were 4 to 32 times higher than for the parental strains. All of the mutants showed a significant increase in chloramphenicol (8 to 64 times), tetracycline (4 to 16 times), and tigecycline (4 to 16 times) MICs compared to the susceptible parental strains. ␤-Lactam MICs were also increased for the mutants, except for amoxicillin, alone or associated with clavulanic acid, imipenem, meropenem, and doripenem. This increase was always significant, whatever the mutant, for cefoxitin and cefuroxime (MICs 4 to 16 times higher than for the parental strains) and inconsistently significant for ticarcillin, cefazolin, cefotaxime, and ceftazidime (2 to 8 times) and for ertapenem (2 to 4 times). It is noteworthy that the MICs of all the antibiotics tested were similar for all the strains sharing an overexpressed efflux-related resistance phenotype and the in vitro-selected mutants, as well as the 3 clinical isolates. Table 4 also shows that the transformation of the ramR and soxR mutants with the wild-type ramR and soxR genes, respectively, restored the strains' susceptibility to all the antibiotic families that are substrates of the efflux systems. The contribution of the wild-type regulator genes to susceptibility to amoxicillin, alone or associated with clavulanic acid, ticarcillin, and cefazolin, could not be evaluated because the pSC-A-amp/ kan plasmid used for transformation harbored a bla gene responsible for high-level resistance to penicillins and first-generation cephalosporins.
DISCUSSION
It has previously been shown in K. pneumoniae clinical isolates that efflux system overexpression results in cross-resistance to different families of antibiotics, including quinolones, chloramphenicol, tetracycline, tigecycline, and ␤-lactams (13, 21, 28, 29, 37) . In this study, we showed the possibility of obtaining in vitro mutants displaying this cross-resistance as a result of antibiotic pressure exerted either with cefoxitin (the most impaired molecule within ␤-lactams) or with a fluoroquinolone (i.e., ciprofloxacin or levofloxacin). To obtain such mutants, we followed the procedure described by Miller et al. for the molecules with low endogenous resistance potential (22) . However, it is noteworthy that, when cefoxitin was used, mutants with another kind of antibiotic resistance pattern could be selected: a low level of resistance to cefoxitin and full susceptibility to nalidixic acid and chloramphenicol. The mechanism explaining this single resistance to cefoxitin was not investigated in this study, but according to recently published data, porin alteration seems to be the most plausible hypothesis (3).
We had previously shown in K. pneumoniae clinical isolates that cefoxitin, quinolone, and chloramphenicol cross-resistance was not always associated with an increase in the transcription level of the genes encoding AcrAB, the most frequently investigated efflux pump in Enterobacteriaceae (3) . Interestingly, such a feature was also found in one of our 17 mutants, KPBj5 M1 
